`

Cogent Biosciences

Biotechnology Research

Specialities :
Gastrointestinal stromal tumors (gist)
Oncology
Systemic mastocytosis
And kinase inhibitors
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$225.0M
size-icon Size
201 - 500

Frequently Asked Questions About Cogent Biosciences

What does Cogent biosciences do?+

Cogent Biosciences is a biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogents lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has already exhibited promising early clinical activity and safety in a Phase...

What are Cogent biosciences's specialties? +

Gastrointestinal stromal tumors (gist),oncology,systemic mastocytosis,and kinase inhibitors

What is Cogent biosciences's industry? +

Cogent biosciences operates in the Biotechnology research industry.

What is Cogent biosciences's revenue? +

Cogent biosciences's revenue is 11m - 100m

What is Cogent biosciences's company size? +

Cogent biosciences has 201 - 500 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.